智通财经APP讯，复星医药(02196)发布公告，上海复星医药(集团)股份有限公司(以下简称“本公司”)于2025年3月27日接到控股股东上海复星高科技(集团)有限公司(以下简称“复星高科技”)的通知，其已将所持有本公司的部分A股股份办理质押手续。本次质押股份数量为3000万股，占本公司股份总数比例1.12%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.